Evidence brief · Supplement

Royal Jelly for Menopausal symptoms

Evidence grade C — Small trials

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Menopausal symptomsEvidence grade C

    Small trials

    Smalllow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Menopausal symptoms (grade C).

The evidence in words

The verdict

For menopausal symptoms, Royal Jelly earns evidence grade C (small effect, low consistency) — the evidence is limited or mixed. Small trials

How it might work

It contains unique fatty acids (10-HDA) and proteins with mild estrogenic, antioxidant and lipid-modulating actions.

How to use it

Safety & cautions

Generally tolerated, but a potent allergen — can cause serious reactions (asthma, anaphylaxis) in sensitive people. Avoid with bee/pollen allergy.

Bottom line

A bee product with modest, real lipid and menopausal signals — but a meaningful allergy risk and a lot of overreach in marketing. Middling.

Goes with

  • Royal JellyRead the full Royal Jelly monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.